海藻酸钾
- 网络Potassium Alginate
![海藻酸钾](../cache/1187854.jpg)
-
海藻酸钾试食组主要临床症状积分降低,与安慰剂对照组及试食前比较差异有统计学意义(P0.05)。
The main clinical symptom score in Potassium alginate group was significantly lower than that before the test and that in control group ( P 0.05 ) .
-
低分子海藻酸钾降压作用及药动学的实验研究
Antihypertensive Effect and Pharmacokinetics of Low Molecular Mass Potassium Alginate
-
结论海藻酸钾散剂与寿比山具有相似的降压疗效,是一种安全、有效的降压药。
Conclusion The efficacy and safety of potassium alginate for hypertension was similar to indapamide .
-
海藻酸钾试食组试食期间静息心率与试食前比较有所下降,但与安慰剂对照组相应时点静息心率比较差异无统计学意义。
The resting heart rate of patients in Potassium alginate group descended significantly compared with that detected before the test , but no significant difference was observed when it compared with that in placebo control group .